Wednesday, January 04, 2023 4:16:01 PM
Why not explore other options to achieve funding to try to finally get Tollovir to market, or Tollovid approved for long covid (it's obvious the current strategy is a failure). Say, an aggregator, who will provide non dilutive funding for Todos to complete Phase III on Tollovir in exchange for future royalties on sales.
I am not in the industry,and would never pretend to be. But GC needs to swallow his pride, step aside, and let experts guide this company. He has had plenty of time. He failed. Not due to lack of trying. Rather due to inexperience.
Just floating some ideas to finally get this thing moving. Because, God knows, nothing else is working.
As stagnant as an abandoned cesspool.
Recent TOMDF News
- Form 15-12G - Securities registration termination [Section 12(g)] • Edgar (US Regulatory) • 07/17/2023 12:29:32 PM
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM
ECGI Holdings Targets $9.7 Billion Equestrian Apparel Market with Allon Brand Launch • ECGI • Jun 25, 2024 8:36 AM
Avant Technologies Addresses Progress on AI Supercomputer-Driven Data Centers • AVAI • Jun 25, 2024 8:00 AM
Green Leaf Innovations, Inc. Expands International Presence with New Partnership in Dubai • GRLF • Jun 24, 2024 8:30 AM
Bemax Inc. Positions to Capitalize on Industry Growth with New Improved Quality of Mother's Touch® Disposable Diapers • BMXC • Jun 24, 2024 8:00 AM
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM